Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab

Name: Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab
Published: 2011
License: Public Domain

University Health Network, Toronto · 2011

ClinicalTrials.gov · Datasets · License: Public Domain · 2011

Open Source ↗

anti-inflammatory

wet macular degeneration, macular degeneration, age-related macular degeneration, anti-inflammatory, anti-vascular endothelial growth factor (anti-vegf), lucentis, ranibizumab, kenalog, triamcinolone acetonide, vision loss, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab

Related documents